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Distinct integration patterns of different retroviruses,
including HIV-1, have puzzled virologists for over
20 years. A tetramer of the viral integrase (IN) assem-
bles on the two viral cDNA ends, docks onto the
target DNA (tDNA), and catalyzes viral genome inser-
tion into the host chromatin. We identified the amino
acids in HIV-1 IN that directly contact tDNA bases
and affect local integration site sequence selection.
These residues also determine the propensity of
the virus to integrate into flexible tDNA sequences.
Remarkably, natural polymorphisms INS119G and
INR231G retarget viral integration away from gene-
dense regions. Precisely these variants were associ-
ated with rapid disease progression in a chronic
HIV-1 subtype C infection cohort. These findings
link integration site selection to virulence and viral
evolution, but also to the host immune response
and antiretroviral therapy, since HIV-1 IN119 is under
selection by HLA alleles and integrase inhibitors.
INTRODUCTION
The retroviral life cycle is characterized by a key integration step
in which a DNA copy of the viral RNA genome is inserted into the
host chromatin. In the past decade, significant progress has
been made in understanding this process. Massive integration
site sequencing revealed that different retroviruses show distinct
preferences with regard to the chromatin environment. Lentiviral
integrase (IN) co-opts the cellular chromatin reader lens epithe-
lium-derived growth factor/p75 (LEDGF/p75; PSIP1) (Ciuffi
et al., 2005) to target integration into active genes. Gammaretro-
viral integration, on the other hand, is enriched near strong en-
hancers and transcription start sites by an interaction betweenCell Host &IN and bromodomain and extraterminal domain (BET) proteins
(BRD2, BRD3, and BRD4; BRD2–4) (De Rijck et al., 2013; Gupta
et al., 2013; Sharma et al., 2013). It is, however, the viral inta-
some, a tetramer of IN assembled on the two viral cDNA ends,
that catalyzes the final DNA cutting and joining reactions and
thus determines the precise position of integration. Before
strand transfer can proceed, the intasome has to dock onto
target (nucleosomal) DNA (tDNA), forming the target capture
complex (TCC) (Maertens et al., 2010). Molecular recognition be-
tween intasome and tDNA imposes specific constraints on the
implicated sequence.
Already in 2001, patient-derived viral INs were employed to
propose that residue IN119 plays a role in target site selection
on naked DNA templates in vitro (Harper et al., 2001). However,
a mechanistic basis for these observations was lacking. The
tools for this would only become available in 2010, when crystal
structure of the prototype foamy virus (PFV) intasome TCC was
reported (Maertens et al., 2010). This model provides insight
into the retroviral integrationmachinery and suggests how the in-
tasome recognizes and docks onto tDNA. Recently, this struc-
ture was used to show that central tDNA distortion in the HIV-1
TCC is spread out over two overlapping dinucleotides surround-
ing the integration site palindrome dyad axis (Serrao et al., 2014).
Additionally, the authors demonstrated that residue S119 in HIV-
1 IN is indeed analogous to A188 in PFV IN, and that INS119A and
INS119T substitutions can alter target site selection of recombi-
nant IN protein into naked DNA substrates in vitro. The effect
of tDNA contacting amino acids (aa) on integration site selection
in a viral context, however, remains largely unstudied.
In this work, we combined structural information on the PFV
TCC with conservation in retroviral IN protein alignments to
determine aa-tDNA base contacts. We generated HIV-1 variants
based on the observed variability at these positions, as-
sessed replication capacities, and performed integration site
sequencing to reveal their integration preferences. Altered mo-
lecular recognition in the TCC underlying distinct local tDNA
nucleotide biases was extrapolated to other retroviral genera.
Finally, we examined the global integration profile of theseMicrobe 16, 651–662, November 12, 2014 ª2014 Elsevier Inc. 651
Figure 1. IN Residues Contacting tDNA Bases
(A) Cartoon of the PFV intasome target capture complex. Boxes on either side zoom in on the aa-tDNA base contacts in the HIV-1 intasome model. Only the IN
CCD a2 helix containing residues S119 and T122, and part of the CTD b1/b2 loop harboring R231, are shown. Proximal tDNA bases are depicted and numbered
starting from the sites of strand transfer on both strands.
(B) The IN CCD a2 helix and CTD b1/b2 regions from a lentiviral sequence alignment are matched with the PFV IN sequence. Numbering refers to the (Gag)-Pol
polyprotein context. Secondary structures and Mg2+ cofactor binding are indicated above, and HIV-1 positions 119, 122, and 231 below, the PFV sequence.
Accession: PFV (P14350); HIV-1 (P03367); HIV-2 (P04584); SIV, simian immunodeficiency virus (Q8AII1); FIV, feline immunodeficiency virus (P31822); BIV, bovine
immunodeficiency virus (P19560); JDV, Jembrana disease virus (Q82851); EIAV, equine infectious anemia virus (P32542); CAEV, caprine arthritis encephalitis
virus (P33459); OMVV, ovine maedi visna-related virus (P16901); MVV, maedi visna virus (P03370). See also Figure S1.
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1 infection cohort.
RESULTS
S119 and R231 of HIV-1 IN Directly Contact tDNA Bases
In the PFV, TCC interactions between IN and tDNA are extensive.
Most, however, involve the DNA phosphodiester backbone and
do not directly impose sequence specificity (Maertens et al.,
2010). Homology modeling of the HIV-1 TCC based on the PFV
structure predicts only two sites of direct aa-tDNA base contact
in HIV-1 IN: S119 and R231. INS119 (INA188 in PFV) is located in
the catalytic core domain (CCD) a2 310-helix, and its side chain
directly projects into the tDNA minor groove, contacting bases
at positions 2 and 3 on one strand and 6 and 7 on the com-
plementary, as counted from the sites of strand transfer (Fig-
ure 1A). INR231, the HIV-1 equivalent of PFV INR329, reaches out
from the C-terminal domain (CTD) b1/b2-loop into the tDNA ma-
jor groove, where it interacts with bases 0 and 1 on one strand
and 4 and 5 on the complementary (Figure 1A). This interaction is
believed to contribute to tDNA deformation (Maertens et al.,
2010).652 Cell Host & Microbe 16, 651–662, November 12, 2014 ª2014 ElsAlthough INS119 and INR231 are the only two sites of direct
tDNA base recognition in HIV-1 IN, modeling suggests that addi-
tional contacts can be introduced. While aa side chains of IN120-
121 face away from the tDNA minor groove and may affect tDNA
contacts indirectly at best, INT122 (INT191 in PFV) points toward
the tDNA again. HIV-1 INT122 is still in close proximity to tDNA
bases, and a long, flexible aa (e.g., Lys) at this position could
represent another handle on the tDNA.
As HIV-1 IN aa 119, 122, and 231 are in direct contact with
tDNA bases, we reasoned that substitutions at these positions
would result in novel molecular interaction patterns between
the intasome and tDNA, in turn giving rise to altered local integra-
tion site preferences.
IN Amino Acids Contacting tDNA Bases Vary among
Lentiviruses
In a breadth-first approach to assess conservation at these IN
positions, we aligned lentiviral (and retroviral) Pol protein se-
quences obtained from UniProt (Figures 1B and S1 available on-
line). Inspection of the alignment in and around the CCD a2 helix
shows overall conservation of this region. In agreement with the
limited amount of space in the tDNA minor groove, positionsevier Inc.
Figure 2. Replication of tDNA Contact Variant Viruses
(A) Transduction efficiency as measured by fLuc reporter activity (relative light units, RLUs/mg protein) 3 days postinfection of SupT1 cells for the indicated HIV-
1NL4-3-fLuc carrying IN mutants. Activity is reported as percentage of HIV-1NL4-3-fLuc carrying WT IN. Data represent averages and SDs from triplicate mea-
surements. Significant deviations from WT are indicated (*p < 0.01, t test).
(B and C) Viral breakthrough experiments of HIV-1NL4-3 WT and INS119A/P/T viruses (colored as in A) in MT-4 cells (B) and PBMCs (C). See also Figure S2.
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Ser, Thr). Positions corresponding to HIV-1 IN122 also harbor
substantial variation. Interestingly, feline immunodeficiency virus
(FIV) encodes a Lys residue at this position, which may directly
contact tDNA bases.
More divergence is present in the CTD b1/b2-loop; next to
substitutions, insertions and deletions are also present, compli-
cating the retroviral alignment (Figures 1B and S1). In accor-
dance with a possible role in tDNA binding, conservation is
higher again at positions corresponding to HIV-1 IN231. Only
equine infectious anemia virus (EIAV) does not encode a basic
Lys or Arg tether, but a Gly instead.
Amino Acids Contacting tDNA Bases Can Be Varied
without Compromising Viral Fitness
Wenext wondered how introduction of the observed aa into HIV-
1 would affect the virus. Therefore, substitutions at IN positions
119, 122, and 231 were introduced into multiple-round HIV-
1NL4-3 and in the single-round firefly luciferase reporter version,
HIV-1NL4-3-fLuc. At position IN119 we generated S119A/P/T sub-
stitutions (Table S1). As previously observed, a long and flexible
aa at position IN122 may directly contact tDNA bases. As Lys was
observed at the equivalent position in FIV IN (FIV INK124), we
introduced a T122K substitution (Figures 1B and S1; Table S1).
At the third tDNA base contact point, HIV-1 IN231, we investi-
gated R231K and R231G substitutions (Table S1). As a control
for our model and to corroborate its tethering role in HIV-1, we
also included an INR231E substitution, in analogy to the previously
reported recombinant PFV INR329E (Maertens et al., 2010).
Single-round HIV-1NL4-3-fLuc viruses carrying the different IN
variants were produced, and their transduction efficiency was
assessed in SupT1 and HeLa P4 cells (Figures 2A and S2A,
respectively). Viral variants INS119A/P/T and INT122K maintained
wild-type (WT) transduction efficiency. Alterations at position
IN231 were tolerated as well; a conservative INR231K substitution
resulted in WT activity, while removal of this basic tether in the
INR231G virus resulted in a trend toward lower transduction effi-
ciency (88.3% ± 0.3% of WT). However, inversion of the charge
at this position (INR231E) severely hampered transduction (3.1%±
0.7% of WT, p < 0.01, t test). For comparison, we included HIV-Cell Host &1NL4-3-fLuc virus containing the enzymatically dead IN catalytic
triadmutant D64N/D116N/E152Q. Thismutant exhibited a trans-
duction efficiency 3–4 log lower than WT virus (data not shown).
To confirm their activity, we determined the replication capac-
ity of the HIV-1NL4-3 IN variants in a multiple-round viral break-
through assay in MT-4 cells and peripheral blood mononuclear
cells (PBMCs). Multiple-round replication was monitored by
measuring viral p24 production in the supernatant. All three
INS119 mutant viruses exhibited growth kinetics comparable to
WT HIV-1NL4-3 corroborating the results of the fLuc assay (Fig-
ures 2B and 2C). The INR231G/K variants also replicated similarly
to WT, while INT122K virus lagged behind (Figures S2B and S2C).
As expected, INR231E virus did not replicate on either MT-4 cells
or PBMCs.
These results indicate that substitutions of tDNA base-con-
tacting aa in IN do not necessarily affect the viral transduction
efficiency or fitness.
Altering HIV-1 Intasome tDNA Contacts Locally
Retargets Viral Integration
Retroviral INs show weak, but discernable, target sequence
specificity at the site of integration. To assess whether the
above-mentioned substitutions alter the local integration site
preferences, we infected SupT1 and HeLa P4 cells with the
respective HIV-1NL4-3 viruses and employed 454 technology to
sequence proviral integration sites. A total of 36,264 distinct sites
were retrieved, 31,615 in SupT1 (Table S2) and 4,649 in HeLa P4
cells (data not shown). The 15 base pair (bp) genomic DNA
sequence surrounding the integration site roughly corresponds
to the intasome footprint. Sequence conservation and relative
base frequencies in this region were evaluated using sequence
logos.
Figure 3A shows the local, palindromic integration site
sequence logo for WT HIV-1NL4-3 (INS119-T122-R231). Most notable
is the bias against thymine at the site of strand transfer (position
0) and a corresponding symmetrical bias against adenine at po-
sition 4 (the point of strand transfer on the complementary
strand). The intasome structure suggests that a thymine C5-
methyl is incompatible with the transesterification reaction
(Maertens et al., 2010). Further away from the palindrome dyadMicrobe 16, 651–662, November 12, 2014 ª2014 Elsevier Inc. 653
Figure 3. Integration Site Sequence Logos of HIV-1NL4-3 IN Variants
Sequence conservation is indicated as the total height of each stack (measured in bits), while the relative height of bases in a stack reflects base frequencies at
that position. Arrows on the HIVNL4-3WT logo (A) indicate the sites of strand transfer (position 0) on the plus (black) andminus (gray) target DNA strands. On top is a
B-DNA cartoon of the tDNA and aa-base contacts where positions directly correspond to the sequence logo below.
(B–I) Integration site sequence logos for the indicated HIV-1NL4-3 variants. Positions showing an altered base distribution compared toWT HIV-1NL4-3 are colored
(*p < 104, c2 test).
(J) Integration site sequence logo for EIAV. See also Figures S3 and S4.
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are the bases contacting IN119 (Figures 3A and S3A). WT HIV-
1NL4-3 IN codes for Ser at this position, inducing a small predilec-
tion for thymine at position3 through aweak hydrogen bonding654 Cell Host & Microbe 16, 651–662, November 12, 2014 ª2014 Elsinteraction between the S119 hydroxyl and the complementary
adenine N3 at position 7 (Figure S3A). G:C bp are disfavored at
position 3, as the presence of a guanine C2 amino group in
the minor groove would sterically hinder the Ser side chain.evier Inc.
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2 IN, resulted in stronger nucleotide biases (Figure 3B). c2 ana-
lyses comparing base distributions at each position to those
observed forWTHIV-1NL4-3 indicate significantly different prefer-
ences at positions 4, 3, 2, and symmetrically 6 and 7 (p <
104). The smaller Ala allows the CCD a2 helix to approach the
tDNA bases more closely. Van der Waals interactions with the
methyl side chain are established, preferably involving a guanine
base at position 3 and a complementary cytosine at 7 (Fig-
ure S3B). Modeling also suggests a polar contact between the
Ala backbone NH and the neighboring 2 thymine C2 carbonyl,
or adenine N3. This interaction is not possible with a G:C bp due
to its bulky guanine C2 amino group in theminor groove, explain-
ing the bias for A:T bp at this position.
INS119P substitution gives rise to small additional sequence
biases at positions 4 and complementary 8, suggesting that
contacts may be established with these bases as well (Figures
3C and S3C). Preferences distinct from those of WT HIV-1NL4-3
are also observed at positions 2, 3 and 6, 7. Pro residues
are frequently observed tomake extensive ring-stacking interac-
tions with adenine, and to a lesser extent, thymine (Luscombe
et al., 2001), rationalizing the novel predilections. Due to the
more optimal van der Waals interactions, INS119P virus generally
prefers 3 R:Y 7 bp to 3 Y:R 7 bp (International Union of
Biochemistry and Molecular Biology base notation).
Increasing the volume of the INS119 side chain by substitution
with Thr, as present in EIAV, results in a strong preference for A:T
bp at positions 3 and 7, while leaving the remainder of the logo
unaffected (Figure 3D). Our model suggests that the INS119T side
chain can engage either a thymine C2 carbonyl or adenine N3 in
a hydrogen bonding interaction (Figure S3D), whereas the addi-
tional minor groove bulk associated with a G:C bp is sterically
disfavored.
Sequence logo analysis of HIV-1NL4-3 INT122K integration sites
shows a decreased bias at position 3 (and 7) compared to WT
(Figure 3E), suggesting that additional tDNA contacts can be
introduced at IN122. While we cannot exclude the possibility
that the INT122K substitution causes a slight shift of the CCD a2
helix, altering interactions with INS119, the observed loss of bias
likely reflects the broad hydrogen bonding capacities of Lys
with minor groove bases (Figure S3E) (Luscombe et al., 2001).
As expected, the conservative INR231K substitution, occurring
in several lentiviral INs, does not alter the local integration site
preferences (Figure 3F). Both the WT Arg (Figure S3F) and the
variant Lys side chain can contact tDNA bases at positions 1,
0 and 4, 5 to balance the energetic penalty accompanying the
strong central tDNA bending (Figure S3G). Both aa are relatively
promiscuous in establishing hydrogen bonding interactions with
major groove bp and do not impose overly specific sequence re-
quirements (Luscombe et al., 2001; Maertens et al., 2010).
Analysis of INR231G virus integration sites reveals that
sequence biases at positions 1, 0 and complementary 4, 5
are reduced (Figure 3G), with significant decreases (> five SDs)
in the proportion of guanine at the former two positions and of
cytosine at the latter. Both the WT INR231 and the variant
INR231K side chains will optimally engage a position 0 guanine
base in a bidentate hydrogen bonding interaction (Figures S3F
and S3G) (Luscombe et al., 2001). The INR231G virus, however,
is stripped of this interaction (Figure S3H). Simultaneously,Cell Host &increased preferences for thymine and adenine are observed
at positions 1 and 3, respectively, hinting at an increased fre-
quency of flexible TAA, AAA, AAT trinucleotides at the integration
site center (positions 1–3; Figure 3G) (Gabrielian and Pongor,
1996; Satchwell et al., 1986). To balance the energetic penalty
for tDNA bending, integration into more flexible sequences
may be required in the absence of a central Arg or Lys tether.
The INR231E virus integration site sequence logo showed an
increased bias toward cytosine at the site of strand transfer (Fig-
ure 3H). In this case a novel hydrogen bonding interaction can be
established between the Glu side chain and a cytosine C4-amino
group (Figure S3I) (Luscombe et al., 2001). An increased bias for
cytosine was observed for PFV INR329E-mediated integration
in vitro (Maertens et al., 2010). However, in this context, the
bias appeared at the base just 50 to the site of strand transfer.
In conclusion, substitutions at positions IN119, IN122, and IN231
result in local retargeting of HIV-1 integration.
HIV-1NL4-3 INS119T-R231G Mimics EIAV Local Integration
Site Preferences
Different retroviruses exhibit distinct nucleotide preferences at
their local integration site. Introduction of single aa substitutions
in HIV-1NL4-3 IN allows mimicry of local preferences of the
respective viruses. Comparing positions 4 to 2 in HIV-1NL4-3
INS119P and FIV (Figures 3C and S4B) reveals preferences for
the same nucleotides (W, R, and T at 4, 3, and 2, respec-
tively). Likewise, biases toward R and W at respective positions
3 and2 for HIV-1NL4-3 INS119A are also observed for HIV-2 and
SIV (Figures 3B, S4C, and S4D). To assess whether the same
molecular interaction patterns govern local integration site selec-
tion for lentiviruses, and by extension, retroviruses, we attemp-
ted to shift the HIV-1 local integration site preference toward
that of EIAV (Figure 3J). EIAV IN contains T119, V122, and
G229, matching HIV-1 IN positions 119, 122, and 231. Intro-
ducing either single aa substitution INS119T or INR231G altered
the integration site nucleotide preferences of HIV-1NL4-3. As
INV122 is unlikely to interact directly with tDNA, we created an
HIV-1NL4-3 INS119T-R231G double mutant. Sequence logo analysis
of viral integration sites in SupT1 cells reflects a merger between
the effects observed for the single IN substitutions: a strong bias
toward A:T bp at positions 3 and 7 and increases in their pres-
ence around the palindrome dyad axis (Figure 3I). Of note, the
central base itself (position 2) also exhibits a significantly height-
ened bias toward A:T bp, which was not observed for the INS119T
or INR231G viruses (Figures 3D and 3G). Overall, integration site
base preferences of the HIV-1NL4-3 INS119T-R231G virus are similar
to those of EIAV, indicating close mimicry of the tDNA base inter-
actions in the EIAV intasome.
Patient-Derived HIV Sequences Reveal Further
Polymorphisms at IN119
Complementary to our breadth-first approach evaluating IN se-
quences of different lenti- and retroviruses, we exploited the
large number of patient-derived HIV IN sequences contained in
the Los Alamos HIV Sequence Database to obtain an in-depth
view on the variability at tDNA base contact positions.
Figure 4A summarizes the sequence conservation and aa
frequencies at positions IN119, IN122, and IN231 for 2,276
aligned HIV-1 sequences. Interestingly, all aa observed in otherMicrobe 16, 651–662, November 12, 2014 ª2014 Elsevier Inc. 655
Figure 4. HIV IN tDNA Contacts Variants and Their Replication
(A and B) Sequence conservation (indicated in bits) and aa frequencies of (A) 2,276 aligned HIV-1 and (B) 72 HIV-2 sequences at positions IN119, IN122, and IN231.
(C) Transduction efficiency as measured by fLuc reporter activity (relative light units, RLUs/mg protein) 3 days postinfection of SupT1 cells for the indicated HIV-
1NL4-3-fLuc single-round viruses. fLuc reporter activity is reported as percentage of HIV-1NL4-3-fLuc carrying WT IN. Data represent averages and SDs from
triplicate measurements. Significant deviations from WT are indicated (*p < 0.01, t test).
(D and E) Viral breakthrough experiments of HIV-1NL4-3 WT and INS119G/R viruses, colored as in (C), on MT-4 cells (D) and PBMCs (E). See also Figures S2 and S5.
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substitutions to Gly or Arg and less frequently to Lys or Ile are
found at IN119. HIV-1 IN122 allows less diversity, with Thr occur-
ring most frequently, followed by Ile, Val, and Ala. The strongest
conservation is found at position IN231, where the entropy ap-
proaches four bits; Arg is preferred, followed by Lys, and occa-
sionally Gly.
Of note, we also split up the results with respect to the different
HIV-1 groups and subtypes. Distinct aa frequencies exist at IN119
when comparing viral groups, subtypes, and circulating recom-
binant forms (Figure S5). Regardless of the higher conservation,
similar observations could bemade for IN positions 122 and 231.
In particular, INR231K was found among subtype B only, while
INR231G substitution was unique for subtype C, although the
limited number of sequences may preclude finding of these var-
iants among other subtypes.
Analysis of 72 HIV-2 sequences is shown in Figure 4B. Aside
from the highly frequent Ala at position IN119, Pro, Ser, and Val
are also encountered. At position IN122, Thr and Ala are found
with nearly equal probabilities. Arg is the only aa found at HIV-
2 IN231. Indubitably, the smaller sample size plays a role in this
finding. Nevertheless, it further underscores the contribution of
INR231 to tDNA binding.
Based on these results, we generated and characterized
additional single-round HIV-1NL4-3-fLuc and multiple-round
HIV-1NL4-3 INS119G/R/K/V/I variants. Transduction efficiency in
SupT1 and HeLa P4 cells revealed that INS119G/R/K viruses main-
tained WT transduction efficiency (Figures 4C and S2D, respec-
tively). Substitution by themore inflexible, bulky Val and Ile at this
position caused a 2- and 30-fold reduction in fLuc signal, respec-
tively (p < 0.01, t test). Clinically relevant INS119G/R variants656 Cell Host & Microbe 16, 651–662, November 12, 2014 ª2014 Elsexhibited growth kinetics similar to WT virus in a multiple-round
infection assay in MT-4 cells and PBMCs (Figures 4D and 4E).
INS119K virus also replicated similarly to WT, while the INS119I
variant did not break through, and INS119V virus exhibited an in-
termediate phenotype (Figures S2E and S2F).
Naturally Occurring HIV-1 IN119 Variants Exhibit Distinct
Local Integration Preferences
If a close approach between the CCD a2 helix and tDNA allows
the formation of additional polar contacts as suggested for
HIV-1NL4-3 INS119A, then the INS119G variant should demonstrate
this more clearly. Indeed, integration site analysis shows an
increased preference for thymine at position 2 (Figure 5B).
Additionally, a second weak electrostatic interaction is estab-
lished in this case, between the polar Gly Ca-H and the C2
carbonyl group of a pyrimidine base (Figure S3J). Together
with increased van der Waals contacts with a 3 G:C 7 bp,
this likely results in the observed preferences at nucleotide 3.
The close approach allows contacts to be established at posi-
tions 4 and 8 as well, giving rise to clear nucleotide biases.
Base distributions at the sites of strand transfer are distinct
from WT. Biases against thymine at position 0 and the comple-
mentary adenine at 4 are alleviated (> five SDs). Slight changes
in the overall tDNA binding mode permitted by the close fit be-
tween the INS119G CCD a2 helix and the tDNA minor groove
may be enough to reduce clashes with the thymine C5-methyl
during transesterification. A trend toward this effect was also
observed for the INS119A virus (p values of 0.0017 and 0.024 for
positions 0 and 4, respectively).
Comparing sequence logos for the INS119V (Figure 5C) and
INS119T viruses underscores the value of the hydrogen bondevier Inc.
Figure 5. Integration Site Sequence Logos of HIV-1NL4-3 IN Variants
(A–F) Local integration sites obtained for (A) HIV-1NL4-3 WT and variants (B) INS119G, (C) INS119V, (D) INS119I, (E) INS119K, and (F) INS119R. Positions showing an
altered base distribution compared to WT HIV-1NL4-3 (A) are colored (*p < 10
4, c2 test). See also Figure S3.
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1NL4-3-fLuc INS119V virus indeed showed a 2-fold reduction in
infectivity. With the loss of the hydrogen bonding potential, the
selectivity for A:T bp at positions3 and 7 is weakened. Howev-
er, the slightly larger Val side chain also establishes contacts
around this position (Figure S3K). Increased preferences for
the smaller A:T bp are apparent at positions 4 to 2 (and 6–
8) at the cost of the more bulky G:C.
Further increase in the aa bulk in the INS119I mutant produced a
considerably crippled virus. As a result, we retrieved insufficient
canonical integration sites (n = 114) to draw solid conclusions on
its nucleotide biases (Figure 5D).
The INS119K virus biases against G:C bp at positions 2, 3
(and 6, 7) of the viral integration site (Figure 5E), highlighting
the space factor, but also suggesting the establishment of
hydrogen bonding between the Lys ε-amino group and a
thymine C2 carbonyl or adenine N3 (Figure S3L). The INS119R
variant also exhibits a bias against G:C bp at the same two posi-
tions (Figure 5F). Additionally, preferences for thymine at position
2 and complementary adenine at 6 are apparent. Interactions
are also established at positions 4 or 8, as a significant prefer-
ence for A:T bp appears (Figure S3M). Base distributions at the
sites of strand transfer are also affected. It is possible that the
size or the interactions of the Arg side chain induce a subtle shift
in the conformation of the tDNA, which is propagated to the
active sites.
IN Amino Acid—tDNA Base Contacts Affect tDNA
Flexibility Requirements
In the intasome, the tDNA major groove is pried open at the
center of the integration site while the minor groove is com-Cell Host &pressed, resulting in a partial destacking of the central bp. In
the case of HIV-1, which catalyzes strand transfer with a 5 bp
instead of a 4 bp stagger as in PFV, this severe bending can
extend over a central trinucleotide instead of a dinucleotide.
In order to investigate the effect of tDNA flexibility on our HIV-
1NL4-3 variants, we grouped the 64 possible trinucleotides (32
considering base complementarity) into three classes (Gabrie-
lian and Pongor, 1996; Satchwell et al., 1986): (i) those that pre-
fer minor groove compression, (ii) those that are stiff/show no
preference, and (iii) those inclined toward major groove
compression. Next, the frequencies of these classes were
determined and compared to those observed for WT HIV-
1NL4-3 (Figure 6A). The INS119I virus was excluded due to its
limited data set.
As expected, the INR231G variant shows an increased ten-
dency to integrate into minor groove-compressible sequences
when compared to WT. This is accompanied by biases against
stiff and major groove-compressible trinucleotides. Both the
INR231K and INR231E viruses did not show altered preferences
regarding central tDNA flexibility. The novel interactions of these
viruses with tDNA bases may balance the energetic penalty
associated with bending.
A remarkable correlation emerges between the bias toward
minor groove-compressible trinucleotides and steric bulk at po-
sition IN119. While the INS119G variant shows a preference for
more rigid sequences, the INS119A/P viruses behave more like
WT, and the bulkier HIV-1NL4-3 INS119T/V show the strongest
bias toward minor groove-compressible trinucleotides. The
INS119K/R viruses, due to their flexible side chains, do not alter
the tDNA flexibility requirements for integration. The EIAV mimic,
HIV-1NL4-3 INS119T-R231G, shows the combined effect of theMicrobe 16, 651–662, November 12, 2014 ª2014 Elsevier Inc. 657
Figure 6. tDNA Bendability and Genomic Integration Preferences
(A) Integration site central trinucleotide (positions 1–3) bendability heat map. Depicted are the changes in frequency of occurrence relative to WT HIV-1NL4-3 for
each of three groups of trinucleotides: those preferring minor groove compression, those that are stiff/show no preference, or those favoring major groove
compression. Statistically significant deviations from the WT HIV-1NL4-3 distribution are indicated (*p < 0.05, c
2 test).
(B) Heat map of the integration frequency relative to genomic features in SupT1 cells. Each column represents a single viral variant, while each row corresponds to
the genomic feature under analysis. Tile color indicates whether a particular feature is favored (red) or disfavored (blue) for integration relative to their matched
random control (MRC). Asterisks indicate deviations (*p < 0.001, Wald statistic, compared to c2 distribution) from the HIV-1NL4-3 WT integration pattern. See also
Figure S6.
Cell Host & Microbe
HIV-1 Integrase Variants Retarget IntegrationINS119T and INR231G substitutions with an even larger bias toward
minor groove-compressible trinucleotides around the integration
site dyad axis.
The INT122K virus is most tolerant of stiff or major groove-
compressible sequences, possibly due to the additional interac-
tions offsetting the energetic penalty of tDNA bending.
HIV-1 IN Variants Display Distinct Global Integration
Profiles
While IN-tDNA base contacts are expected to influence local
integration site biases, this is less evident for the global prefer-
ences. We hence zoomed out and investigated whether our
HIV-1NL4-3 variants exhibit distinct global integration site profiles.
Figure 6B shows heat maps summarizing viral integration prefer-
ences relative to diverse genomic features. The INS119T/V/K/R
viruses all show a reduced tendency to integrate into GC-rich re-
gions of the genome when small windows (20–100 bp) are
considered. This finding is in agreement with their sequence
logos, all of which indicated relatively strong biases toward
adenine or thymine at positions 3 or 2. Looking at window
sizes > 100 bp, this predilection fades, except for the INS119V
virus, which shows an integration profile shifting away from658 Cell Host & Microbe 16, 651–662, November 12, 2014 ª2014 Elsgene-dense regions. INS119T/K/R viruses show global integration
profiles comparable to WT. Like INS119V, INS119G virus integrates
less into globally gene-dense regions, albeit to a more limited
extent, as evidenced, for example, by the smaller reduction in
bias for GC content over large window sizes. The integration
site profile of the INS119A variant appears intermediate between
that of INS119G and WT, while INS119P virus integrates similarly
to WT.
Turning to the IN231 variants, also with regard to the global
integration site distribution the INR231K virus is indistinguishable
from WT. INR231G/E viruses shift integration away from gene-
dense regions as well, with the latter showing themost potent ef-
fect. The INT122K virus has a global profile indistinguishable from
that of WT.
Finally, HIV-1NL4-3 INS119T-R231G virus combines the integration
profile shifts observed for the separate INS119T and INR231G var-
iants and integrates markedly less in gene-dense regions.
Analysis of integration sites relative to epigenetic features for
these viruses (Figure S6A) revealed shifts and preferences corre-
sponding to those observed in the genomic heatmap. HIV-1NL4-3
variants INS119T/P/K/R, INT122K, and INR231K are virtually indistin-
guishable from WT when looking at their global integrationevier Inc.
Figure 7. Influence of Retargeting Polymorphisms on Disease Characteristics
(A and B) Influence of IN119 and IN231 polymorphisms in a chronic HIV-1 subtype C infection cohort on (A) CD4
+ T cell counts at baseline and (B) the rate of CD4+
T cell decline. p values are indicated when significant (p < 0.05) or almost significant.
(C) Proviral transcriptional activity measured as mean YFP fluorescence intensity of SupT1 cells 5 days postinfection with the indicated HIV-1NL4-3 IRES-YFP
single-round viruses. Data represent averages and SDs from triplicate measurements. n.t., nontransduced.
(D) Percentage caspase-1- or caspase-3-positive PBMCs after breakthrough of the indicated HIV-1NL4-3 variants. Uninfected and staurosporine-treated PBMCs
are included as controls. See also Figure S7.
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INS119T-R231G viruses exhibit retargeting to regions with a
reduced activation status. INS119A virus again shows a behavior
in between that of WT and INS119G. Although we obtained amore
limited number of integration sites for the different sets in HeLa
P4 cells, the genomic distributions paralleled those observed
in SupT1 cells (data not shown).
HIV IN positions 119, 122, and 231 are not expected to alter
LEDGF/p75 binding. To confirm that integration of these
variants is still globally targeted by LEDGF/p75, we mapped
chromosomal binding of LEDGF/p75 by ChIP-seq and deter-
mined the enrichment of LEDGF/p75 peaks in the vicinity of
integration sites compared to MRC sites. The bottom row in
Figure 6B indicates that all viral variants are similarly inclined
to integrate into LEDGF/p75-bound regions. To further
exclude an effect of the globally retargeting IN substitutions
on LEDGF/p75 binding, we performed AlphaScreen protein-
protein interaction assays. Titration of recombinant His6-
tagged INWT, INS119G, or INR231G against FLAG-tagged
LEDGF/p75 resulted in comparable binding curves, confirm-
ing that the recognition of this cofactor is unaffected by the
substitutions (Figure S6B).
In addition, we also evaluated whether S119G or R231G sub-
stitutions influence IN multimerization, a key process during viral
replication. Employing a previously reported IN multimerization
AlphaScreen assay (Demeulemeester et al., 2012), we titrated
recombinant His6-IN WT or variants against the correspondingCell Host &glutathione S-transferase (GST)-tagged IN versions. Both
INS119G and INR231G displayed a similar multimerization behavior
as WT (Figure S6C).
INS119G and INR231G Are Associated with Rapid Disease
Progression in a Chronic Infection Cohort
We next wondered whether the altered integration site selection
of our variants affects disease characteristics. To address this,
we looked at the Sinikithemba cohort, which comprises antire-
troviral-naive, HIV-1 subtype C chronically infected adults
enrolled at the McCord Hospital (Durban, South Africa) from
August 2003 to December 2008. We considered a set of 85 par-
ticipants from the cohort for which IN sequences and longitudi-
nal follow-up data were available. Of these, 74 encoded Ser, 7
Thr, 2 Arg, and only 1 Gly at position IN119 against a WT INR231
background. One viral isolate had an INR231G substitution in a
WT INS119 context.
Analysis of CD4+ T cell counts at baseline did not reveal any
significant differences among the viral variants, although a trend
toward lower CD4+ T cell counts was observed for INS119R vi-
ruses (Figure 7A). Interestingly, both globally retargeting viral
variants, INS119G and INR231G, were associated with rapid dis-
ease progression as reflected by the higher rate of CD4+ T cell
decline compared to WT virus (INS119-R231, Figure 7B, mixed
linear model, p = 0.0220 and p = 0.0078, respectively).
Considering that the viral fitness and transduction efficiency of
these variants are comparable to WT, altered transcription of theMicrobe 16, 651–662, November 12, 2014 ª2014 Elsevier Inc. 659
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test this hypothesis, we generated HIV-1NL4-3 single-round
viruses carrying a yellow fluorescent protein (YFP) reporter be-
tween the env and nef genes using an internal ribosome entry
site (IRES; HIV-1NL4-3 IRES-YFP). SupT1 and HeLa P4 cells
were infected with serial dilutions of HIV-1NL4-3 IRES-YFP car-
rying the INS119G/R/T or INR231G variants, and harvested for
fluorescence-activated cell sorting (FACS) analysis 5 days post-
infection. The mean fluorescence intensity obtained with virus
dilutions giving rise to a low percentage of YFP+ cells (< 20%,
single integrated copy) was used as a measure of provirus tran-
scriptional activity. Expression levels did not differ significantly
between IN variant viruses (Figures 7C and S7A). Comparable
data were obtained after culturing the infected cells for 10 days
(data not shown).
Lastly, we askedwhether we could detect increased cell death
following infection with HIV-1NL4-3 INS119G or INR231G, which may
explain the higher rate of CD4+ T cell decline in patients. HIV
infection of CD4+ T cells has been reported to induce both
caspase-3-mediated apoptosis as well as inflammatory cas-
pase-1-mediated pyroptosis (Doitsh et al., 2014). While
apoptosis occurs in a minority of productively infected cells,
the majority of quiescent CD4+ T cells die through pyroptosis
triggered by abortive infection. We used fluorescently labeled in-
hibitor of caspase (FLICA) probes to monitor caspase activation
during a spreading infection in PBMCs. At day 7, coinciding with
full viral breakthrough, we observed increased activation of both
caspase-1 and -3 (Figures 7D and S7B). Neither INS119G nor
INR231G virus induced more activation than WT. It is, however,
likely that the limited timeframe as well as the in vitro setting
are unable to capture the differences in the slow decay of
CD4+ T cells observed in patients.
Despite the limited number of patients with rare IN polymor-
phisms, these data suggest that globally retargeting IN polymor-
phisms, such as INS119G and INR231G, could be linked to HIV
pathogenesis. Although similar levels of transcriptional activity
and cell death were detected for both variants in cell culture,
we cannot exclude that these factors contribute to the increased
rate of CD4+ T cell decline in patients over time.
DISCUSSION
While it is clear how IN-tDNA base contacts can affect local
integration site preferences, this is far less the case for the
global retargeting effects. Several hypotheses can be formu-
lated. First, there may exist other, as yet unknown, cofactors
aside from LEDGF/p75 (or HRP-2; Schrijvers et al., 2012) that
contribute to integration site selection. We show that LEDGF/
p75 binding is unaffected, but cannot exclude that the globally
retargeting IN variants affect binding to other cofactors. Sec-
ond, reduced IN strand transfer activity may increase the life-
time of the PIC as it will not integrate as quickly. The additional
time could allow the PIC to travel further into the nucleus to re-
gions not normally targeted. Such an effect could play a role for
the partially defective INS119V and INR231E variants. Third, based
on the intasome model and the tDNA flexibility effects, we hy-
pothesize that substitutions INS119G/V and INR231G/E reduce the
shape and/or electrostatic compatibility of the intasome with
nucleosomal tDNA. As intergenic regions are believed to exhibit660 Cell Host & Microbe 16, 651–662, November 12, 2014 ª2014 Elslower nucleosome occupancy than coding regions, this could
explain the observed shift toward globally less gene-dense
regions.
The prevalence of retargeting IN variants differs among HIV-1
subtypes (Figure S5). Overall, we hence expect slightly different
integration site preferences for one subtype when compared to
another. Notably, based on the available viral sequences, the
globally retargeting INS119G and INR231G variants appear to occur
more frequently in subtypes B and C, respectively. As different
subtypes are associated with different rates of disease progres-
sion (Vasan et al., 2006), it would be interesting to test whether
part of this variability can be explained by differences in integra-
tion site targeting. Subtype D viruses, for instance, show an over-
all higher prevalence of globally retargeting variants and are
associated with faster progression toward AIDSwhen compared
to subtype A or C (Vasan et al., 2006).
Our findings reveal a number of intriguing interplays. First, HIV
integration into gene-dense regions of the genome is hypothe-
sized to afford the provirus better access to transcription factors
(Schro¨der et al., 2002). Targeting integration away from these re-
gions, such as in the IN119G and IN231G variants, could thus result
in altered transcriptional regulation of the provirus. In turn, this
may directly affect latency and disease progression, suggesting
interaction between the integration neighborhood and virulence
or viral evolution. Although we did not detect gross transcrip-
tional or cytotoxicity differences in cell culture, subtle effects
may exist in the patient, which accumulate over time.
Second, the INS119R variant was recently described as an un-
common polymorphism selected by the HLA-C*05 allele (Brock-
man et al., 2012). Immune escape was suggested to result in a
slightly reduced viral replication capacity, which could be
rescued by a single compensatory INA91E mutation. Covariation
between IN positions 91 and 119 or between 119 and 122 in
some HIV-1 subtypes was reported previously (Rhee et al.,
2008). Structurally these aa are in relatively close proximity and
may indeed influence one another. In the TCC, however, the
A91 side chain is directed toward the tDNA phosphodiester
backbone and is unlikely to directly alter tDNA base contacts.
In any case, IN119 represents a site of close interaction between
HIV-1 immune evasion and integration site targeting.
Third, not only do INS119R/G/T variants differ in frequency
among HIV-1 subtypes, they also change prevalence in un-
treated versus IN strand transfer inhibitor (INSTI)-treated pa-
tients, and they have been described as secondary resistance
mutations (Ceccherini-Silberstein et al., 2010). Due to the poly-
morphic nature of this position, however, it is still unclear to
which extent IN119 substitutions contribute to INSTI resistance
(Armenia et al., 2012). INSTIs are competitive inhibitors of
tDNA binding, and it can be expected that energetically more
favorable tDNA contacts at position IN119 and/or slight changes
in the tDNA conformation (as suggested for the INS119R/G vari-
ants) can indirectly decrease INSTI inhibition by increasing
tDNA affinity. Treatment with suboptimal doses of raltegravir
can lead to aberrant HIV-1 integration where a single or both
end(s) of the provirus are associated with duplications, inver-
sions, deletions, and insertions (Varadarajan et al., 2013). Our re-
sults suggest that INSTI treatment, by selecting for certain IN119
polymorphisms, can influence the viral integration site indirectly
as well.evier Inc.
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be the sole direct tDNA base contacts in HIV-1, other positions
may exist which indirectly affect target site selection. The identi-
fication and interpretation of aa with such subtle effects is
considerably more involved, however. For example, a mecha-
nistic explanation has yet to be put forward for variation in the
size of the insertion stagger. In theory, the aa involved could
equally well be polymorphic or under immune selection and
may hence represent further links with integration site selection.
The highly polymorphic A124 and T125 in HIV-1 IN, for example,
are part of the LEDGF/p75 binding site. These residues could
alter target site selection indirectly by affecting cofactor binding.
In conclusion, our findings reveal how polymorphisms at posi-
tions corresponding to HIV IN119 and IN231 affect local as well as
global integration site targeting. Intriguingly, these findings pro-
vide a number of links between integration site selection on the
one hand and immune evasion, antiretroviral therapy, virulence,
and disease progression on the other.
EXPERIMENTAL PROCEDURES
Plasmids and Mutagenesis
The viral molecular clone pNL4-3 and reporter construct pNL4-3.Luc.R-.E-
were obtained through the NIH AIDS Reagent Program, Division of AIDS,
NIAID, NIH. Details on the mutagenesis are included in the Supplemental
Information.
Recombinant Protein Purification
N-terminally GST-tagged and C-terminally His6-tagged IN WT and mutants
were produced and purified as described previously (Busschots et al., 2005;
Demeulemeester et al., 2012). Purification of triple-FLAG-tagged LEDGF/
p75 is outlined in the Supplemental Information.
AlphaScreen Protein-Protein Interaction Assay
The IN multimerization assay was performed essentially as reported before
(Demeulemeester et al., 2012). Details on the IN-LEDGF/p75 AlphaScreen
are presented in the Supplemental Information.
Integration Site Sequencing
Linkers were ligated to MseI-digested genomic DNA isolated from infected
SupT1 and HeLa P4 cells, and virus-host DNA junctions were amplified by
nested PCR. Samples were barcoded through the second pair of PCR primers
in order to generate 454 libraries. PCR products were purified and sequenced
using 454/Roche pyrosequencing (Titanium Technology). Reads were quality
filtered by requiring perfect matches to the long terminal repeat linker and bar-
code and subsequently mapped to the human genome. Details are included in
the Supplemental Information.
Virus Production and Transduction
Virus production is described in the Supplemental Information. Lentiviral trans-
duction (HIV-1NL4-3 fLuc, HIV-1NL4-3 IRES-YFP) and infection (HIV-1NL4-3) ex-
periments were performed as reported previously (Schrijvers et al., 2012).
Viral Replication and Caspase Assay
For the breakthrough experiments 105 MT-4 cells or 106 PBMCs were infected
with virus amounting to 0.2 or 20 pg p24/mL, respectively. Starting 2 or 3 days
postinfection, supernatants were sampled daily, and viral replication was as-
sessed using p24 ELISA.
Caspase-1/3 activation was monitored at selected time points using FLICA
probes (ImmunoChemistry Technologies) followed by FACS analysis. Stauro-
sporine (1 mM) was used as a positive control.
Sinikithemba Cohort Analysis
The Sinikithemba cohort comprises 450 antiretroviral naive, HIV-1 subtype C
chronically infected adults. Sociodemographic characteristics, plasma viralCell Host &load, and CD4+ T cell count measurements were obtained at baseline. CD4+
T cell counts and viral loads were measured every 3 and 6 months, respec-
tively, starting from enrollment. Viral loads were determined using the auto-
mated Cobas Amplicor HIV-1 Monitor test (v1.5, Roche Diagnostics). CD4+
T cells were enumerated using the Multitest Kit (CD4/CD3/CD8/CD45) on a
FACSCalibur flow cytometer (Becton Dickinson).
Mann-Whitney U tests were used to assess the association of polymor-
phisms with baseline CD4+ counts. Linear mixed models were employed to
estimate the rate of CD4+ T cell decline. Statistical analyses were done using
SAS v9.3 (SAS Institute) and Prism 5 (GraphPad). Results where p < 0.05 were
considered significant.
Homology Modeling and Bioinformatics
Structural work on the PFV intasome and homology modeling of the HIV-1 in-
tasome were performed with Chemical Computing Group’s Molecular Oper-
ating Environment 2012.10. Sequence alignments were generated using
MSAProbs and visualized and manually realigned using Jalview. Sequence
logos were created using WebLogo 3.3 with compositional adjustment for
the human genome base background distribution. Statistical analyses on
base and trinucleotide distributions were performed using R-3.0.1.
ACCESSION NUMBERS
The GEO accession number for the LEDGF/p75 ChIP-Seq reported in this
paper is GSE61003.
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mental Experimental Procedures and can be found with this article online at
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